ENCORE leverages the hollow cavity of T-sphaera as a linker-free drug delivery modality, enabling the encapsulation of both hydrophobic and hydrophilic payloads with a high loading capacity of up to 60 payloads per scaffold—far exceeding conventional ADC capacity.